JP2023538066A5 - - Google Patents
Info
- Publication number
- JP2023538066A5 JP2023538066A5 JP2023511906A JP2023511906A JP2023538066A5 JP 2023538066 A5 JP2023538066 A5 JP 2023538066A5 JP 2023511906 A JP2023511906 A JP 2023511906A JP 2023511906 A JP2023511906 A JP 2023511906A JP 2023538066 A5 JP2023538066 A5 JP 2023538066A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formulation
- subject
- day
- formulation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063067786P | 2020-08-19 | 2020-08-19 | |
| US63/067,786 | 2020-08-19 | ||
| PCT/US2021/046591 WO2022040371A1 (en) | 2020-08-19 | 2021-08-19 | Methods for treating hypercholesterolemia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538066A JP2023538066A (ja) | 2023-09-06 |
| JP2023538066A5 true JP2023538066A5 (https=) | 2024-08-23 |
| JP7824930B2 JP7824930B2 (ja) | 2026-03-05 |
Family
ID=77693631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023511906A Active JP7824930B2 (ja) | 2020-08-19 | 2021-08-19 | 高コレステロール血症の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12472171B2 (https=) |
| EP (1) | EP4199928B1 (https=) |
| JP (1) | JP7824930B2 (https=) |
| CN (1) | CN116056702B (https=) |
| WO (1) | WO2022040371A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021013807A2 (pt) | 2019-01-18 | 2021-11-30 | Astrazeneca Ab | Inibidores de pcsk9 e seus métodos de uso |
| MX2021008661A (es) | 2019-01-18 | 2021-08-19 | Astrazeneca Ab | Inhibidores de la pcsk9 y metodos de uso de los mismos. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2002053568A1 (ja) * | 2000-12-28 | 2004-05-13 | 持田製薬株式会社 | スピロ結合を有する三環系化合物を有効成分とするコレステロール生合成阻害剤 |
| PL1643983T3 (pl) * | 2003-06-24 | 2010-10-29 | Univ Connecticut | Sposoby hamowania przepuszczalności naczyń krwionośnych i apoptozy |
| EA034451B1 (ru) * | 2011-02-07 | 2020-02-10 | Байоджен Ма Инк. | Модуляторы s1p |
| JP6324380B2 (ja) * | 2012-07-27 | 2018-05-16 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | Ｓ１ｐ調節剤および／またはａｔｘ調節剤である化合物 |
| US20230390270A1 (en) * | 2020-08-19 | 2023-12-07 | Biogen Ma Inc. | Methods for treating remitting multiple sclerosis |
-
2021
- 2021-08-19 US US18/021,654 patent/US12472171B2/en active Active
- 2021-08-19 CN CN202180050829.0A patent/CN116056702B/zh active Active
- 2021-08-19 EP EP21766793.0A patent/EP4199928B1/en active Active
- 2021-08-19 JP JP2023511906A patent/JP7824930B2/ja active Active
- 2021-08-19 WO PCT/US2021/046591 patent/WO2022040371A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Keating et al. | Carvedilol: a review of its use in chronic heart failure | |
| US8481570B2 (en) | 1-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities | |
| JP2022545835A5 (https=) | ||
| JP5524438B2 (ja) | ロテプレドノールと抗ヒスタミン薬の新規な組み合わせ物 | |
| US20220000824A1 (en) | Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acid | |
| JP2024540183A5 (https=) | ||
| JP2011522896A (ja) | 低用量トピラメート／フェンテルミン組成物およびその使用方法 | |
| JP2004522714A5 (https=) | ||
| CN1917866A (zh) | 曲前列环素治疗和预防缺血性损害的用途 | |
| JP2023538066A5 (https=) | ||
| RU2012110592A (ru) | Соединения и способ снижения мочевой кислоты | |
| JP2014507476A (ja) | 高尿酸血症および高尿酸血症関連代謝障害を治療するための方法および組成物 | |
| US11147781B2 (en) | Methods for alleviating statin myopathy | |
| US10363235B2 (en) | Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same | |
| JP2024524273A5 (https=) | ||
| JP2002508320A (ja) | スタチン−カルボキシアルキルエーテル配合物 | |
| RU2004115023A (ru) | Фапмацевтическая композиция, содержащая (r)-бикалутамид | |
| JP2009545546A (ja) | リウマチ性疾患の遅延放出型グルココルチコイド治療 | |
| EP4003368A1 (en) | Treatment comprising sglt inhibitors, e.g. sglt 1/2 inhibitors | |
| JP2010505866A5 (https=) | ||
| JP2024520020A5 (https=) | ||
| McKenney | Combination therapy for elevated low-density lipoprotein cholesterol: the key to coronary artery disease risk reduction | |
| US12257228B2 (en) | Cardioversion methods using budiodarone | |
| WO2020223893A1 (en) | Use of gold nanoclusters in treating hypercholesterolemia or hypercholesterolemia-associated diseases | |
| JP7356968B2 (ja) | 心血管疾患に有用な医薬 |